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16 YOUNG INVESTIGATORS
ATTEND RESEARCH COURSE
The second annual ASBMT Trans-
plant Clinical Research TrainingCourse
is being held July 30 to Aug. 4 in Park
City, Utah. Sixteen young clinicians
and investigators are participating.
The five-day course assists fellows
and young faculty in career paths
toward successful clinical research in
blood and marrow transplantation.
The participants were selected com-
petitively from among submitted
applications, each including a pro-
posed research project.
Major funding for the clinical re-
search training course is being pro-
vided by Amgen, Histogenetics,
Merck, Otsuka Pharmaceuticals and
THERAKOS.
The selected scholars are:
 Jeffery Auletta, MD, Case Western
Reserve University, Rainbow
Babies and Children’s Hospital,
Cleveland, Ohio
 Jonathan Benjamin, MD, PhD,
Stanford University Medical Center
 Christina Castilla-Llorente, MD,
PhD, Fred Hutchinson Cancer
Research Center
 William Clark, MD, MS, Vanderbilt
University
 Sung Choi, MD, University of
Michigan Cancer Center
 Luciano Costa, MD, PhD, Medical
University of South Carolina
 David Delgado, MD, University of
Wisconsin Children’s Hospital
 Christine Duncan, MD, Dana-
Farber Cancer Institute
 Hong Liu, MD, PhD, University of
Florida Shands Cancer Center
 Chrystal Louis, MD, MPH, Baylor
College of Medicine
 Taiga Nishihori, MD, Yale Univer-
sity School of Medicine
 Iskra Pusic, MD, Washington
University School of Medicine
 Jessica Shafer, MD, Baylor College
of Medicine
 Sophie Stein, MD, University of
Pennsylvania
 Jonathan Storey, MD, Wake Forest
Comprehensive Cancer Center
 Jeffrey Venstrom, MD, Memorial
Sloan-Kettering Cancer Center
The course directors are Daniel
Weisdorf, MD, of the University of
Minnesota, and Nelson Chao, MD,
of Duke University. They, together
with nine other faculty members, are
leading the sessions, as well as shar-
ing their career stories and counsel.
Free time for rest, recreation and crea-
tive thinking is built into the schedule.
Other members of the faculty are:
 Tracy Bergemann, PhD, University
of Minnesota
 Chris Bredeson, MD, MSc, Medical
College of Wisconsin
 Corey Cutler, MD, MPH, Dana-
Farber Cancer Institute
 Stella Davies, MD, PhD, Cincinnati
Children’s Hospital
 Armand Keating, MD, University of
Toronto/PrincessMargaret Hospital
 Ginna LaPort, MD, Stanford Uni-
versity
 Brent Logan, PhD, Center for Inter-
national Blood and Marrow Trans-
plant Research
 Jeffrey Miller, MD, University of
Minnesota
 Robert Soiffer, MD, Dana-Farber
Cancer Institute
ACCREDITATION, REIMBURSEMENT
DISCUSSED WITH HRSA PANEL
Representatives of ASBMT testified
on several key issues in a two-day
hearing of the HRSA Advisory Council
on Blood Stem Cell Transplantation.
Organized early this year, the council
advises on implementation of the
C.W. "Bill" Young Cell Transplantation
Program and the National Cord Blood
Inventory (NCBI).
Dr. Roy Jones, chair of the ASBMT
Committee on Quality Outcomes,
addressed concerns about Medicare
and private insurer reimbursement
for stem cell transplantation. He em-
phasized the need for a Medicare
National Coverage Determination
for allotranplants for myelodysplastic
diseases, lymphoma, myeloma and
Hodgkin’s disease, and as well as tan-
dem autotransplants for myeloma.
He urge the advisory council to
seek clarification from the Centers for
Medicare and Medicaid Services
(CMS) on its clinical trials policy, urging
that the agency should reimburse for
indications for which there is no na-
tional "non-coverage" decision.
Dr. Rob Soiffer, ASBMT past-presi-
dent, testified in support of the Foun-
dation for the Accreditation of Cellular
Therapy (FACT) as best positioned to
set standards and provide accredita-
tion for cord blood banks under the
NCBI program. "FACT standards are
universally recognized in our field and
are known, copied or imitated by gov-
ernments and accrediting agencies
throughout the world," he said.
AABB also is seeking advisory coun-
cil recognition for its cord blood bank
standards and accreditation program.
Among other topics on the advisory
council’s agenda were public funding
for required data documentation,
confidentiality for cord blood donors,
FDA progress in the regulation of cord
blood banks, access to cord blood
units for research, and comparative
results post-transplant for bone mar-
row vs. peripheral blood stem cell vs.
cord blood grafts.
The Advisory Council’s next meeting
is in November.
FACT LAUNCHES E-NEWSLETTER
The Foundation for the Accredita-
tion of Cellular Therapy has launched
an electronic newsletter with informa-
tion about standards and accredita-
tion for transplant centers and cord
blood banks.
Thenewsletter is intended tobea re-
source for accredited and applicant
blood stem cell collection centers, pro-
cessing laboratories and clinical facili-
ties, as well as cord blood banks and
accreditation inspectors
To subscribe to the free newsletter,
contact FACT at fact@unmc.edu.946
